NVCR241220P00017500 Option on Novocure

NVCR Stock  USD 20.04  0.35  1.78%   

Novocure Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Novocure Market Cap Over Time

   Market Cap   
       Timeline  

Novocure Total Stockholder Equity

Total Stockholder Equity

279.71 Million

At this time, Novocure's Total Stockholder Equity is relatively stable compared to the past year.

Novocure Corporate Management

Piet MDHead VPProfile
William BurkeChief OfficerProfile
Frank LeonardExecutive OncologyProfile
Uri MDChief OfficerProfile
Pritesh ShahChief Commercial OfficerProfile
Ashley CordovaChief OfficerProfile

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.